Alcyone Therapeutics hopes to be a standout star and rising goddess in the central nervous system (CNS) treatment landscape. The Massachusetts biotech unveiled itself Wednesday with $23 million in ...
Expanded collaboration with Nationwide Children's Hospital adds new funding and a third therapeutic candidate (CLN-301) to Alcyone's diversified portfolio of precision CNS therapeutics and delivery ...
Biogen has given Alcyone Therapeutics a starring role in its drug delivery strategy, paying $85 million to buy the biotech and take control of an implant for getting medicines into the spinal canal.
Alcyone’s ThecaFlex DRx™ System is an implantable medical device in development for intrathecal drug delivery CAMBRIDGE, Mass. and LOWELL, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: ...
Biogen and Alcyone Therapeutics (Alcyone) have entered into a collaboration and licensing agreement to develop Alcyone’s ThecaFlex DRx System (ThecaFlex) to improve patient experience and access to ...
LOWELL — Alcyone Lifesciences Inc., a biotech startup that moved its headquarters to the Boott Mill last summer, said it has entered into an “exclusive clinical collaboration” with Houston-based ...
Hosted on MSN
Biogen acquires Alcyone to boost CNS drug delivery
Biogen has completed its previously announced acquisition of US-based Alcyone Therapeutics, for an upfront cash payment of $85m, to boost central nervous system (CNS) drug delivery. In September 2025, ...
Biogen is set to acquire US-based Alcyone Therapeutics. Biogen has an existing partnership with Alcyone, and both companies are developing a device that has the potential to improve how medications ...
Alcyone: The Last City is an interactive sci-fi novel in which the player's choices heavily impact the overall narrative, opening or closing pathways through the story, and greatly affecting the end ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback